115 related articles for article (PubMed ID: 8763853)
41. Suramin increases p53 protein levels but does not activate the p53-dependent G1 checkpoint.
Howard SP; Park SJ; Hughes-Davies L; Coleman CN; Price BD
Clin Cancer Res; 1996 Feb; 2(2):269-76. PubMed ID: 9816169
[TBL] [Abstract][Full Text] [Related]
42. Unique induction of p21(WAF1/CIP1)expression by vinorelbine in androgen-independent prostate cancer cells.
Liu XM; Jiang JD; Ferrari AC; Budman DR; Wang LG
Br J Cancer; 2003 Oct; 89(8):1566-73. PubMed ID: 14562033
[TBL] [Abstract][Full Text] [Related]
43. Overexpression of p21(waf1) decreases G2-M arrest and apoptosis induced by paclitaxel in human sarcoma cells lacking both p53 and functional Rb protein.
Li W; Fan J; Banerjee D; Bertino JR
Mol Pharmacol; 1999 Jun; 55(6):1088-93. PubMed ID: 10347252
[TBL] [Abstract][Full Text] [Related]
44. Low dose fractionated radiation enhances the radiosensitization effect of paclitaxel in colorectal tumor cells with mutant p53.
Chendil D; Oakes R; Alcock RA; Patel N; Mayhew C; Mohiuddin M; Gallicchio VS; Ahmed MM
Cancer; 2000 Nov; 89(9):1893-900. PubMed ID: 11064345
[TBL] [Abstract][Full Text] [Related]
45. Pretreatment with DNA-damaging agents permits selective killing of checkpoint-deficient cells by microtubule-active drugs.
Blagosklonny MV; Robey R; Bates S; Fojo T
J Clin Invest; 2000 Feb; 105(4):533-9. PubMed ID: 10683383
[TBL] [Abstract][Full Text] [Related]
46. Induction of the WAF1/CIP1 protein and apoptosis in human T-cell leukemia virus type I-transformed lymphocytes after treatment with adriamycin by using a p53-independent pathway.
Gartenhaus RB; Wang P; Hoffmann P
Proc Natl Acad Sci U S A; 1996 Jan; 93(1):265-8. PubMed ID: 8552618
[TBL] [Abstract][Full Text] [Related]
47. Potentiating effect of obacunone from Dictamnus dasycarpus on cytotoxicity of microtuble inhibitors, vincristine, vinblastine and taxol.
Jung H; Sok DE; Kim Y; Min B; Lee J; Bae K
Planta Med; 2000 Feb; 66(1):74-6. PubMed ID: 10705741
[TBL] [Abstract][Full Text] [Related]
48. Flavopiridol inversely affects p21(WAF1/CIP1) and p53 and protects p21-sensitive cells from paclitaxel.
Blagosklonny MV; Darzynkiewicz Z; Figg WD
Cancer Biol Ther; 2002; 1(4):420-5. PubMed ID: 12432259
[TBL] [Abstract][Full Text] [Related]
49. Survival of colorectal cancer cell lines treated with paclitaxel, radiation, and 5-FU: effect of TP53 or hMLH1 deficiency.
Kennedy AS; Harrison GH; Mansfield CM; Zhou XJ; Xu JF; Balcer-Kubiczek EK
Int J Cancer; 2000 Aug; 90(4):175-85. PubMed ID: 10993958
[TBL] [Abstract][Full Text] [Related]
50. A novel p21WAF1/CIP1 transcript is highly dependent on p53 for its basal expression in mouse tissues.
Gartel AL; Radhakrishnan SK; Serfas MS; Kwon YH; Tyner AL
Oncogene; 2004 Oct; 23(49):8154-7. PubMed ID: 15361845
[TBL] [Abstract][Full Text] [Related]
51. Differential expression of p53, p21waf1/cip1 and hdm2 dependent on DNA damage in Bloom's syndrome fibroblasts.
Collister M; Lane DP; Kuehl BL
Carcinogenesis; 1998 Dec; 19(12):2115-20. PubMed ID: 9886565
[TBL] [Abstract][Full Text] [Related]
52. DNA damage increases sensitivity to vinca alkaloids and decreases sensitivity to taxanes through p53-dependent repression of microtubule-associated protein 4.
Zhang CC; Yang JM; Bash-Babula J; White E; Murphy M; Levine AJ; Hait WN
Cancer Res; 1999 Aug; 59(15):3663-70. PubMed ID: 10446979
[TBL] [Abstract][Full Text] [Related]
53. Synergistic antitumor effects of novel HDAC inhibitors and paclitaxel in vitro and in vivo.
Zuco V; De Cesare M; Cincinelli R; Nannei R; Pisano C; Zaffaroni N; Zunino F
PLoS One; 2011; 6(12):e29085. PubMed ID: 22194993
[TBL] [Abstract][Full Text] [Related]
54. Synergistic interaction between topotecan and microtubule-interfering agents.
Bahadori HR; Green MR; Catapano CV
Cancer Chemother Pharmacol; 2001 Sep; 48(3):188-96. PubMed ID: 11592339
[TBL] [Abstract][Full Text] [Related]
55. Sequence-dependent antagonism between fluorouracil and paclitaxel in human breast cancer cells.
Grem JL; Nguyen D; Monahan BP; Kao V; Geoffroy FJ
Biochem Pharmacol; 1999 Aug; 58(3):477-86. PubMed ID: 10424768
[TBL] [Abstract][Full Text] [Related]
56. A p21/WAF1 mutation favors the appearance of drug resistance to paclitaxel in human noncancerous epithelial mammary cells.
Galmarini CM; Bouchet BP; Audoynaud C; Lamblot C; Falette N; Bertholon J; Wang Q; Beghin A; Dumontet C; Puisieux A
Int J Cancer; 2006 Jul; 119(1):60-6. PubMed ID: 16432835
[TBL] [Abstract][Full Text] [Related]
57. Induction of p53 without increase in p21WAF1 in betulinic acid-mediated cell death is preferential for human metastatic melanoma.
Rieber M; Strasberg Rieber M
DNA Cell Biol; 1998 May; 17(5):399-406. PubMed ID: 9628583
[TBL] [Abstract][Full Text] [Related]
58. p53 accumulates in micronuclei after treatment with a DNA breaking chemical, methylnitrosourea, and with the spindle poison, vinblastine.
Granetto C; Ottaggio L; Abbondandolo A; Bonatti S
Mutat Res; 1996 Jun; 352(1-2):61-4. PubMed ID: 8676917
[TBL] [Abstract][Full Text] [Related]
59. The cytoprotective aminothiol WR1065 activates p21waf-1 and down regulates cell cycle progression through a p53-dependent pathway.
North S; El-Ghissassi F; Pluquet O; Verhaegh G; Hainaut P
Oncogene; 2000 Feb; 19(9):1206-14. PubMed ID: 10713709
[TBL] [Abstract][Full Text] [Related]
60. Oocyte-based screening system for anti-microtubule agents.
Shin DY; Choi TS
J Reprod Dev; 2004 Dec; 50(6):647-52. PubMed ID: 15647616
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
